Sanofi(SNY)

PARIS, FrancePharmaceutical1 H-1B visas (FY2023)

Focus: Sanofi is a global Big Pharma company with 91,000 employees headquartered in Paris, France, operating across small molecules, biologics, immunology, oncology, vaccines, and rare diseases.

Immunology Oncology Neurology Rare Diseases

Profile data last refreshed 3h ago · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Employees

91,000

Open Jobs

About Sanofi

AI assessmentNot Hiring

No open roles listed right now. Follow Sanofi to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

4/9 — Basic

Company HealthWatch

Pipeline

Early-stage

50 total

LOE Risk

2 imminent

FEXINIDAZOLE

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

LANTUS SOLOSTAR

Type 1 & 2 Diabetes Mellitus

$3.2B

LOE Approaching

Sanofi's largest revenue driver, but facing biosimilar erosion and approaching loss of exclusivity; represents ~47% of company revenue.

Help build intelligence for Sanofi

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Pipeline & Clinical Trials

Investigational Procedures

Sphingomyelin Lipidosis

N/A

Clinical Trials (1)

NCT04106544A Prospective and Retrospective Cohort Study in Patients With Chronic Forms of Acid Sphingomyelinase Deficiency (ASMD)

N/A

Efluelda® Pre-filled syringe

Influenza Immunization

N/A

Clinical Trials (1)

NCT07282795Post-marketing Surveillance Study for the Safety of Efluelda® Pre-filled Syringe

N/A

Insulin

Type 1 Diabetes

N/A

Clinical Trials (5)

NCT00384215Insulin Glargine [rDNA Origin] Injection vs Pioglitazone as add-on Therapy in Patients Failing Monotherapy With Sulfonylurea or Metformin

Phase 4

NCT00911625Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency

Kidney Information Network for Disease Research and Education

ESRD

N/A

Clinical Trials (1)

NCT03321604Kidney Information Network for Disease Research and Education

N/A

Observatory on Elderly Patients "Les S.AGES"

Diabetes Mellitus, Type 2

N/A

Clinical Trials (1)

NCT01065909Observatory on Elderly Patients "Les S.AGES"

N/A

Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)

Optic Neuritis

N/A

a live attenuated chimeric JE vaccine

Japanese Encephalitis

N/A

Clinical Trials (2)

NCT02526550Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAX

Phase 4

NCT02602652Immunogenicity of a JE-CV as a Booster Dose After a Primary Vaccination With SA14-14-2 Vaccine

Retrospective Safety Survey In Patients Included In NV1FGF Clinical Trials

Peripheral Arterial Occlusive Disease

N/A

Clinical Trials (1)

NCT01135797Retrospective Safety Survey In Patients Included In NV1FGF Clinical Trials

N/A

Flublok Quadrivalent influenza vaccine RIV4

Influenza

N/A

Clinical Trials (1)

NCT04460781Surveillance Study to Assess the Safety of Flublok Quadrivalent (Influenza Vaccine) in Pregnant Women and Their Offspring

N/A

Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registr

Acute Leukemia

N/A

Clinical Trials (2)

NCT01362985Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor

N/A

NCT01362972Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Patients Receiving Plerixafor

Bevacizumab

Lung Cancer

N/A

Clinical Trials (5)

NCT00335595Study of Bevacizumab Alone or Combined With Capecitabine and Oxaliplatin as Support Therapy in Metastatic Colorectal Cancer Patients

Phase 3

NCT00208546Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer

AZD6244

Thyroid Cancer

N/A

DUPIXENT®

Asthma

N/A

Clinical Trials (5)

NCT04959448Study Assessing Long-teRm Outcomes of dupiluMAb (DUPIXENT®) Treatment in Adult Patients With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)

N/A

NCT03992417Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)

Menactra®: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate

Meningitis

N/A

Clinical Trials (4)

NCT01270503Post-Marketing Safety Study of Menactra® in Healthy Children, Adolescents, and Adults in the Philippines

Phase 4

NCT00539032Immunology and Safety of Menactra® in Children in Saudi Arabia

Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients

Prostatic Neoplasms

N/A

Clinical Trials (1)

NCT01076751Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients

N/A

RIAT Registry: Reason for Not Intensifying Antihypertensive Treatment

Hypertension

N/A

Plerixafor

Bone Marrow / Autologous Transplants

N/A

Clinical Trials (5)

NCT05087212Mobilization of Stem Cells With AMD3100 (Plerixafor) in Combination With G-CSF in Multiple Myeloma Patients

Phase 4

NCT02006225Stem Cell Harvesting Using GCSF Plus Plerxiafor, in First -Line, for Heavily Pre- Treated Pediatric Oncology Patients.

Dupilumab - Standard Dose

Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)

N/A

Clinical Trials (1)

NCT06892704Olfactory Cleft Obstruction and Electrophysiological Field Potentials Predict Olfactory Restoration by Dupilumab in CRSwNP Patients.

N/A

A Study in Male and Female Adolescent Participants With Severe Uncontrolled Asthma Starting Treatmen

Asthma

N/A

Clinical Trials (1)

NCT05070663A Study in Male and Female Adolescent Participants With Severe Uncontrolled Asthma Starting Treatment With Dupilumab Injection (Dupixent®)

N/A

Nasopharyngeal sampling

Bordetella Pertussis, Whooping Cough

N/A

Clinical Trials (1)

NCT03388034Pertussis Immunization Programs in Low Income Countries - Ivory Coast

N/A

Sepraspray

Adhesion Prevention

N/A

Clinical Trials (3)

NCT00624390Sepraspray™ Laparoscopic Myomectomy Study

N/A

NCT00778479Evaluation of the Safety of Sepraspray in Open Abdominal Surgery

N/A

Brigham and Women's Rheumatoid Arthritis Sequential Study

Rheumatoid Arthritis

N/A

Olipudase alfa

Acid Sphingomyelinase Deficiency (ASMD)

N/A

Clinical Trials (5)

NCT02004691Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency

Phase 2/3

NCT06949358A Study to Evaluate Safety and Tolerability of Olipudase Alfa in Pediatric and Adult Participants With Acid Sphingomyelinase Deficiency (ASMD) Who Completed the DFI12712 or the LTS13632 Study in France

Alglucosidase alfa GZ419829

Glycogen Storage Disease Type II

N/A

Clinical Trials (1)

NCT04848779A Prospective Study to Observe & Describe Clinical Outcomes of Alglucosidase Alfa Treatment in Patients ≤6 Months of Age With Infantile-onset Pompe Disease (IOPD)

N/A

Non-interventional Study on the Monthly Administration of 300 mg AliRocumab (PRALUENT®) With the 2 m

Primary Hypercholesterolaemia and Mixed Dyslipidaemia

N/A

Clinical Trials (1)

NCT05129241Non-interventional Study on the Monthly Administration of 300 mg AliRocumab (PRALUENT®) With the 2 ml SYDNEY Auto-injector

N/A

Blood sampling

Septic Shock

N/A

Clinical Trials (3)

NCT06469359Analyzes of Nasal Tissue-resident Memory Immune Cells and Peripheral Memory Cells Able to Migrate to Airway Tissues (MUCOVAC)

N/A

NCT00929318Influence of Thyroid Hormones on the Woundhealing Process

N/A

intradermal pholcodine allergy test in cases

Neuromuscular Blocking Agents Anaphylaxis

N/A

Patterns of Non-Adherence to Dual Anti-Platelet Regimen In Stented Patients

Medication Non-adherence

N/A

Heparin-Induced Thrombocytopenia: Development and Validation of a Predictive Clinical

Heparin-induced Thrombocytopenia

N/A

Clinical Trials (1)

NCT00748839Heparin-Induced Thrombocytopenia: Development and Validation of a Predictive Clinical

N/A

Non-interventional Translational Study in Mild, Moderate and Severe Acne Patients

Acne

N/A

Clinical Trials (1)

NCT07411638Non-interventional Translational Study in Mild, Moderate and Severe Acne Patients

N/A

Venous Thromboembolism Taskforce Audit Program

Venous Thrombosis

N/A

Clinical Trials (1)

NCT00535171Venous Thromboembolism Taskforce Audit Program

N/A

Observational study

Myopathy

N/A

Clinical Trials (5)

NCT03200626Observational Study to Evaluate Hematopoietic Progenitor Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma

N/A

NCT04023708Observational Study to Evaluate the Safety of CYD Tetravalent Dengue Vaccine (CYD-TDV) in Pregnant Women and Their Offsprings Inadvertently Exposed During Pregnancy

Study of Methodologies to Measure Blood Flow and Oxygenation in Adults With Sickle Cell Disease

Healthy

N/A

Clinical Trials (1)

NCT02447627Study of Methodologies to Measure Blood Flow and Oxygenation in Adults With Sickle Cell Disease

N/A

6 Minute Walk Test

Aged

N/A

Delay between MS onset and introduction of first line DMT

C10.114.375.500

N/A

Clinical Trials (1)

NCT03308994Impact of the Arrival on the French Market of New First Line Oral Treatments on the Delay Between MS Onset and First Disease Modifying Treatment (DMTs) Administration

N/A

Sepraspray

Abdominal Adhesions

N/A

Clinical Trials (1)

NCT00665730Evaluation of the Safety and Effectiveness of Sepraspray™ in Reducing Post-surgical Adhesions

N/A

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Hematologic Disorder

N/A

Blood sample

Dermatitis Atopic

N/A

Clinical Trials (4)

NCT03784898Collection of Blood Samples From Patients With Relapsing MS Who Developed ITP After Receiving Lemtrada

Phase 4

NCT00298428Biological Efficacy of Clopidogrel After Implantation of Drug-eluting Stents (SPACE)

N/A

Real World and Epidemiology Study of Medically Attended Chlamydia Trachomatis Among Adults in German

Chlamydia Trachomatis

N/A

Clinical Trials (1)

NCT07002047Real World and Epidemiology Study of Medically Attended Chlamydia Trachomatis Among Adults in Germany

N/A

Alfuzosin

Kidney Stones

N/A

Clinical Trials (1)

NCT00583258A Randomized Study of Whether Alfuzosin(Xatral) Helps in the Passage of Kidney Stones

N/A

Meningococcal

Meningitis

N/A

Clinical Trials (5)

NCT02864927Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea

Phase 4

NCT01430611Study of Sanofi Pasteur and Lanzhou Institute's Meningococcal (Group A and C) Polysaccharide Vaccine in Children

Phase 4

Zolpidem CR

Dementia

N/A

Clinical Trials (1)

NCT00814502Zolpidem CR and Hospitalized Patients With Dementia

N/A

Seasonal influenza vaccine - VAXIGRIP TETRA influenza vaccine

Arsenic--Toxicology

N/A

Clinical Trials (1)

NCT03930017Pregnancy, Arsenic and Immune Response

N/A

Turkey Thrombotic Thrombocytopenic Purpura Disease Registry: National Multicenter Study

TTP - Thrombotic Thrombocytopenic Purpura

N/A

Clinical Trials (1)

NCT05950750Turkey Thrombotic Thrombocytopenic Purpura Disease Registry: National Multicenter Study

N/A

Financial incentives for increasing physical exercise

Sedentary Lifestyle

N/A

Clinical Trials (1)

NCT01043757Financial Incentives for Increasing Exercise

N/A

Stamaril®

Yellow Fever

N/A

Clinical Trials (1)

NCT03541694Passive Enhanced Safety Surveillance of Stamaril® Vaccine in Korea

N/A

Heparin Induced Thrombocytopenia: Pharmacoeconomics

Heparin Induced Thrombocytopenia (HIT)

N/A

Clinical Trials (1)

NCT00456001Heparin Induced Thrombocytopenia: Pharmacoeconomics

N/A

Screening DIVA - Diffuse Vascular Disease

Peripheral Vascular Diseases

N/A

Pediatric and Ambulatory Research in Infectious Diseases

Otitis

N/A

Quadrivalent Intradermal Influenza Vaccine

Pregnancy

N/A

Clinical Trials (1)

NCT02554409Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry

N/A

Sanofi(SNY)

About Sanofi

Why Work Here

Key Products

Watch Out For

Products & Portfolio (48)

Key Products by Revenue

Other Products (24)

Pipeline & Clinical Trials

Open Jobs (0)

Hiring Trend

Visa Sponsorship

Risk Signals

WARN Act Layoff Notices (1)

Research Publications(10)